Publications by authors named "Fangsheng Fu"

Claim this Profile
A
Antibacterial Peptides-Produced Cell Hydrogel Eliminates Intracellular Pathogens and Remodels Immune Microenvironment for Osteomyelitis Therapy.
Yu Chen, Qi-Wen Chen, Fang-Sheng Fu, Jian-Hua Yan, Junwei Su

ACS Nano· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered enhances bone regeneration via immunoregulation and anti-Infection.
Fang-Sheng Fu, Huan-Huan Chen, Yu Chen, Ying Yuan, Yong Zhao

Bioact Mater· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone Destruction-Chemotactic Osteoprogenitor Cells Deliver Liposome Nanomedicines for the Treatment of Osteosarcoma and Osteoporosis.
Yu Chen, Qi-Wen Chen, Fang-Sheng Fu, Hui-Yun Gu, Aixi Yu

ACS Nano· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tiliroside is a new potential therapeutic drug for osteoporosis in mice.
Kai Li, Yu Xiao, Ziyi Wang, Fangsheng Fu, Siyuan Shao

J Cell Physiol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-Pronged Microbe Delivery of Nitric Oxide and Oxygen for Diabetic Wound Healing.
Huan-Huan Chen, Fang-Sheng Fu, Qi-Wen Chen, Yun Zhang, Xian-Zheng Zhang

Nano Lett· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chrysin Protects Against Titanium Particle-Induced Osteolysis by Attenuating Osteoclast Formation and Function by Inhibiting NF-κB and MAPK Signaling.
Zuoxing Wu, Chen Li, Yu Chen, Qian Liu, Na Li, Fangsheng Fu

Front Pharmacol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ellagic acid protects ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption.
Xixi Lin, Guixin Yuan, Zhaoning Li, Mengyu Zhou, Xianghua Hu, Fangsheng Fu

J Cell Physiol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tiliroside is a new potential therapeutic drug for osteoporosis in mice.
Kai Li, Yu Xiao, Ziyi Wang, Fangsheng Fu, Siyuan Shao

J Cell Physiol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice.
Siyuan Shao, Fangsheng Fu, Ziyi Wang, Fangming Song, Chen Li

J Cell Physiol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pectolinarigenin prevents bone loss in ovariectomized mice and inhibits RANKL-induced osteoclastogenesis via blocking activation of MAPK and NFATc1 signaling.
Yu Xiao, Kai Li, Ziyi Wang, Fangsheng Fu, Siyuan Shao

J Cell Physiol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salidroside promotes rat spinal cord injury recovery by inhibiting inflammatory cytokine expression and NF-κB and MAPK signaling pathways.
Yiji Su, Shaohui Zong, Chengming Wei, Fangming Song, Haotian Feng, Fangsheng Fu

J Cell Physiol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways.
Zuoxing Wu, Hailun Wu, Chen Li, Fangsheng Fu, Jiaxin Ding

J Cell Physiol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scutellarein inhibits RANKL-induced osteoclast formation in vitro and prevents LPS-induced bone loss in vivo.
Fangsheng Fu, Siyuan Shao, Ziyi Wang, Fangming Song, Xixi Lin

J Cell Physiol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis